TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
董秀容TUNG, HSIU-JUNG
- 計畫主持人
- 執行臨床試驗年資 7 年 9 個月
-
thjami@cgmh.org.tw
發表文獻
3筆
1
Huang HJ#, Yang LY#, Tung HJ#, Ku FC, Wu RC, Tang YH, Chang WY, Jung SM, Wang CC, Qiu JT, Lin CT, Huang KG, Chou HH, Chang TC, Chao A*, Lai CH*. Management and clinical outcomes of patients with recurrent/progressive ovarian clear cell carcinoma. J Formos Med Assoc (IF: 3.008). 2020 Apr;119(4):793-804. Epub 2019 Dec 6. equal contribution# (co-first author)
2
Huang HJ, Tung HJ, Yang LY, Chao A, Tang YH, Chou HH, Chang WY, Wu RC, Huang CC, Lin CY, Liao MJ, Chen WC, Lin CT, Chen MY, Huang KG, Wang CJ, Chang TC, Lai CH. Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia. Int J Cancer (IF: 5.145). 2021 Feb 1;148(3):665-672. Epub 2020 Sep 1. (co-author)
3
Chiang CY#, Huang HJ, Chang WY, Yang LY, Wu RC, Wang CC, Tung HJ, Chao A, Lai CH. Adjuvant therapy and prognosis in uterine carcinosarcoma. J Formos Med Assoc (61/246) (IF: 3.008). 2021 May 12:S0929-6646(21)00173-X. doi: 10.1016/j.jfma.2021.04.016. Online ahead of print. PMID: 33992491 (co-author)
